Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-03-02 @ 5:23 AM
Study NCT ID:
NCT01807520
Status:
COMPLETED
Last Update Posted:
2018-03-13
First Post:
2013-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Nail Psoriasis
Sponsor:
Novartis Pharmaceuticals
Organization: